As a result, the majority of these markers (CSF Ng, VILIP-1, sTREM2, SNAP-25) are likely to provide minimal utility in the context of Alzheimer’s disease. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.